Logo image of SDGR

SCHRODINGER INC (SDGR) Stock Price, Quote, News and Overview

NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock - Currency: USD

26.19  +0.44 (+1.71%)

After market: 26.25 +0.06 (+0.23%)

SDGR Quote, Performance and Key Statistics

SCHRODINGER INC

NASDAQ:SDGR (4/21/2025, 8:00:02 PM)

After market: 26.25 +0.06 (+0.23%)

26.19

+0.44 (+1.71%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High28.47
52 Week Low16.6
Market Cap1.91B
Shares73.04M
Float62.19M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)04-30 2025-04-30/amc
IPO02-06 2020-02-06


SDGR short term performance overview.The bars show the price performance of SDGR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

SDGR long term performance overview.The bars show the price performance of SDGR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 -5 -10

The current stock price of SDGR is 26.19 USD. In the past month the price increased by 20.14%. In the past year, price increased by 9.26%.

SCHRODINGER INC / SDGR Daily stock chart

SDGR Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 31.78 34.18B
DOCS DOXIMITY INC-CLASS A 40.06 9.62B
WAY WAYSTAR HOLDING CORP N/A 6.06B
CERT CERTARA INC 32.16 2.34B
GDRX GOODRX HOLDINGS INC-CLASS A 13.24 1.68B
PHR PHREESIA INC N/A 1.37B
TDOC TELADOC HEALTH INC N/A 1.14B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.10B
EVH EVOLENT HEALTH INC - A 12.85 988.68M
HSTM HEALTHSTREAM INC 48 967.19M
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 782.92M
SLP SIMULATIONS PLUS INC 96.86 681.73M

About SDGR

Company Profile

SDGR logo image Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 891 full-time employees. The company went IPO on 2020-02-06. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The firm operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The firm's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.

Company Info

SCHRODINGER INC

1540 Broadway, 24th Floor

New York City NEW YORK 10036 US

CEO: Ramy Farid

Employees: 867

Company Website: https://www.schrodinger.com

Investor Relations: https://ir.schrodinger.com/

Phone: 15032991150

SCHRODINGER INC / SDGR FAQ

What is the stock price of SCHRODINGER INC today?

The current stock price of SDGR is 26.19 USD. The price increased by 1.71% in the last trading session.


What is the ticker symbol for SCHRODINGER INC stock?

The exchange symbol of SCHRODINGER INC is SDGR and it is listed on the Nasdaq exchange.


On which exchange is SDGR stock listed?

SDGR stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for SCHRODINGER INC stock?

16 analysts have analysed SDGR and the average price target is 31.42 USD. This implies a price increase of 19.95% is expected in the next year compared to the current price of 26.19. Check the SCHRODINGER INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SCHRODINGER INC worth?

SCHRODINGER INC (SDGR) has a market capitalization of 1.91B USD. This makes SDGR a Small Cap stock.


How many employees does SCHRODINGER INC have?

SCHRODINGER INC (SDGR) currently has 867 employees.


What are the support and resistance levels for SCHRODINGER INC (SDGR) stock?

SCHRODINGER INC (SDGR) has a support level at 26.18 and a resistance level at 26.2. Check the full technical report for a detailed analysis of SDGR support and resistance levels.


Is SCHRODINGER INC (SDGR) expected to grow?

The Revenue of SCHRODINGER INC (SDGR) is expected to grow by 24.87% in the next year. Check the estimates tab for more information on the SDGR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SCHRODINGER INC (SDGR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SCHRODINGER INC (SDGR) stock pay dividends?

SDGR does not pay a dividend.


When does SCHRODINGER INC (SDGR) report earnings?

SCHRODINGER INC (SDGR) will report earnings on 2025-04-30, after the market close.


What is the Price/Earnings (PE) ratio of SCHRODINGER INC (SDGR)?

SCHRODINGER INC (SDGR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.57).


What is the Short Interest ratio of SCHRODINGER INC (SDGR) stock?

The outstanding short interest for SCHRODINGER INC (SDGR) is 14.85% of its float. Check the ownership tab for more information on the SDGR short interest.


SDGR Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to SDGR. When comparing the yearly performance of all stocks, SDGR is one of the better performing stocks in the market, outperforming 86.82% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SDGR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SDGR. SDGR has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SDGR Financial Highlights

Over the last trailing twelve months SDGR reported a non-GAAP Earnings per Share(EPS) of -2.57. The EPS decreased by -575.93% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -22.73%
ROE -44.4%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-34.15%
Sales Q2Q%19.14%
EPS 1Y (TTM)-575.93%
Revenue 1Y (TTM)-4.21%

SDGR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 81% to SDGR. The Buy consensus is the average rating of analysts ratings from 16 analysts.

For the next year, analysts expect an EPS growth of -1.25% and a revenue growth 24.87% for SDGR


Ownership
Inst Owners98.88%
Ins Owners2.42%
Short Float %14.85%
Short Ratio9.25
Analysts
Analysts81.25
Price Target31.42 (19.97%)
EPS Next Y-1.25%
Revenue Next Year24.87%